Dexmedetomidine in Modifying Immune Paralysis In Patient With Septic Shock
Status:
Unknown status
Trial end date:
2020-03-20
Target enrollment:
Participant gender:
Summary
in this study the investigators aim to assess the role of using dexmedetomidine as sedative
in septic shock patients in comparison with midazolam. The investigators aim to assess the
effect on immune response and inflammatory mediators and effect on vasopressors.